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Holoprosencephaly (HPE), the most common fore-
brain malformation, is characterized by an incom-
plete separation of the cerebral hemispheres. Muta-
tions in the homeobox gene SIX3 account for 1.3%
of all cases of humanHPE. Using zebrafish-based as-
says, we have now determined that HPE-associated
Six3 mutant proteins function as hypomorphs. Hap-
loinsufficiencyofSix3 causedbydeletion of one allele
of Six3 or by replacement of wild-type Six3 with
HPE-associated Six3 mutant alleles was sufficient
to recapitulate in mouse models most of the pheno-
typic features of human HPE. We demonstrate that
Shh is a direct target of Six3 in the rostral diencepha-
lon ventral midline (RDVM). Reduced amounts of
functional Six3 protein fail to activate Shh expression
in themutantRDVMandultimately lead toHPE.These
results identify Six3 as a direct regulator of Shh ex-
pression and reveal a crossregulatory loop between
Shh and Six3 in the ventral forebrain.
INTRODUCTION
Holoprosencephaly (HPE), the incomplete separation of the
cerebral hemispheres, is the most common human forebrain
malformation and is classified into three subtypes (alobar, semi-
lobar, and lobar) on the basis of the severity of the defects
(DeMyer, 1977).
The cause of HPE in humans is heterogeneous and pathoge-
netically variable. Mutations in nine genes have been identified
in HPE patients (Cohen, 2006). Three genes, SHH, PTCH1, and
GLI2, belong to the Sonic hedgehog (Shh) signaling pathway
(Roessler and Muenke, 2003). Mutations in SHH account for
about 17% of familial cases and about 3.7% of all cases of
HPE (Cohen, 2006). In mice, Shh expression in the prechordal
plate (PrCP) causes the separation of the two eye fields and
the proper development of the ventral forebrain (Chiang et al.,
1996). Consequently, the lack of Shh function results in cyclopia,
the most severe form of HPE (Chiang et al., 1996). However, not
much is yet known about the identity of upstream regulators of236 Developmental Cell 15, 236–247, August 12, 2008 ª2008 ElsevShh expression in the ventral forebrain. Mutations in the homeo-
box gene SIX3 account for 1.3% of all cases of HPE (Cohen,
2006). Like other HPE genes, SIX3mutations cause a wide spec-
trum of defects, ranging from cyclopia to microforms (e.g., single
median maxillary central incisor) (Muenke and Cohen, 2000).
Moreover, a single SIX3 mutation can cause HPE with variable
penetrance and expressivity such that a normal parent of a pa-
tient with HPE also harbors the mutation. This finding suggests
that additional genetic or environmental factors are required to
cause HPE (Muenke and Cohen, 2000).
SIX3 is the only HPE gene that has not been directly or indi-
rectly linked to the Shh signaling pathway (Cohen, 2006), and
the molecular mechanisms by which mutations in this gene
lead to HPE remain unknown. During mouse development,
Six3 is initially expressed throughout the anterior neural ecto-
derm (ANE). However, later it becomes restricted to the ventral
forebrain and eye field (Oliver et al., 1995). Functional studies
in mice revealed that Six3 protects the ANE from the posterioriz-
ing activity of Wnt1 via direct repression of Wnt1 transcription
(Lagutin et al., 2003). Consequently, the anterior expansion of
canonical Wnt signaling in Six3 null embryos results in the
absence of the telencephalon and rostral diencephalon (Lagutin
et al., 2003).
Here, we used zebrafish-based functional assays to determine
that HPE-associated Six3 mutations result in decreased activity
of Six3. Detailed characterization of mouse models of Six3-
promoted HPE demonstrated that Six3 directly activates Shh ex-
pression in the rostral diencephalon ventral midline (RDVM) and
that in turn Shh maintains Six3 expression in the RDVM; deletion
of one allele of Six3 or replacement of wild-type Six3 by HPE-
associated mutant Six3 disrupts this positive regulatory loop
and leads to HPE.
RESULTS
HPE-Associated Six3 Mutant Proteins Behave
as Hypomorphs
Eighteen SIX3 mutations have been identified in HPE-affected
individuals. Eleven mutations are located in the Six domain, six
in the homeodomain, and one in the C-terminal region (Wallis
et al., 1999; Nanni et al., 2000; Pasquier et al., 2000, 2005; Du-
bourg et al., 2004; Ribeiro et al., 2006). Of those 18 mutations,
we selected five that were identified in cases of familial HPEier Inc.
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Six3-Promoted Holoprosencephalyfor further analysis (Figure S1A available online). Six3V92G and
Six3H173P have a single amino acid mutation in the Six domain,
and Six3GGins contains a GG insertion in the Six domain that is
predicted to cause premature termination of translation in the
Figure 1. HPE-Associated Six3 Mutants Function
as Hypomorphs
(A–D) The five generated six3b HPE-related mutant forms
can rescue the headless phenotype in injected hdl/tcf3/
mutant embryos. ddH2O and mGFP (250 pg) were injected
as negative controls. Rescue was scored at 55 hr postfer-
tilization (hpf) according to three phenotypic categories:
no rescue (yellow) (A), partial rescue (light blue) (B), and
full rescue (dark blue) (C). The results are graphically
represented in (D), which shows the samples and doses
injected.
(E–H) The six3b mutant forms show hypomorphic activity
in suppressing the eyeless phenotype of six3b;six7 mutant
morphants. The six3bvu87/vu87 mutants injected with six7
antisense morpholino oligonucleotide (MO) exhibit an eye-
less phenotype. After coinjection of six3b mutants with
six7 MO and six3b wild-type or mutant forms, embryos
were graded according to the size of their eyes (0–6.5
point [pt] scale). Examples are shown of absent eyes
(0 pt) (E), severely reduced eyes (arrowhead) (1.2 pt) (F),
moderately reduced eyes (3.0 pt) (G), and full-size eyes
(5.3 pt) (H).
(I) Graphical interpretation of these results. The E109Stop
nullmutation found insix3bvu87mutants wasoverexpressed
as a negative control. Double asterisks indicate eye size
significantly different from that of six3bvu87/vu87-six7mutant
morphants (p% 0.01). The absence of asterisks on mutant
form-injected samples indicates a p value that exceeds
0.05 (statistically insignificant).
(J) Summary of the three zebrafish-based functional as-
says. Five HPE-associated Six3 mutants can be separated
into three groups on the basis of their hypomorphic activity.
homeodomain (Dubourg et al., 2004; Pasquier
et al., 2005). Six3V250A and Six3R257P harbor
a single amino acid substitution in the third helix
of the homeodomain (Wallis et al., 1999).
To unravel the mechanisms by which these
Six3 mutations lead to HPE in humans, we first
performed zebrafish-based in vivo assays
aimed to identify possible changes in the activ-
ities of these mutant proteins. To do this, these
five HPE-associated SIX3 mutations were intro-
duced into six3b, the zebrafish homolog of
mammalian Six3 (Kobayashi et al., 1998), and
their activity was compared to that of wild-
type Six3b in three different assays. The first
assay relied on our previous observation that
injection of synthetic RNA encoding mouse
Six3 rescued the eyeless phenotype of head-
less/tcf3 (hdl–/–) zebrafish mutant embryos
in whichwnt1 expression is anteriorly expanded
(Lagutin et al., 2003; Kim et al., 2000). As shown
in Figures 1A–1D, similar phenotypic rescue
was achieved by injections of very low doses
of six3b RNA; RNAs encoding all five Six3b
HPE-related mutant proteins also rescued the
hdl eyeless phenotype, some almost as efficiently as wild-type
Six3b (Six3V92G), others only when used at higher doses. In
a second assay, we tested the ability of these mutant forms to
suppress the eyeless phenotype of zebrafish embryos deficient
Developmental Cell 15, 236–247, August 12, 2008 ª2008 Elsevier Inc. 237
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Six3-Promoted Holoprosencephalyin two six3-related genes, six3b and six7 (Inbal et al., 2007). Sim-
ilar to the results obtained in the first assay, some of the mutants
suppressed the eyeless phenotype of six3b;six7-deficient em-
bryos only when used at higher doses (Figures 1E–1I). However,
some mutant forms were unable to suppress the eyeless pheno-
type even at high doses, thereby showing no activity in this assay
(Figures 1E–1I). In the final assay, we took advantage of the fact
that injections of synthetic six3bRNA result in dorsalization of the
zebrafish embryo (Figures S1B–S1Q), which is mostly likely due
to the ability of Six3 to repressWnt andBmp expression (Lagutin
et al., 2003; Gestri et al., 2005). The mutant proteins showed
a spectrum of hypomorphic activities that ranged from a slightly
decreased ability to an inability to dorsalize embryos at the
injected doses (Figures S1B–S1Q).
In summary, based on our results from the three assays, the
five HPE-associated Six3 mutant proteins can be separated
into three groups (Figure 1J). Group 1 (Six3bV92G) shows the
strongest hypomorphic activity, group 2 (Six3bV250A and
Six3bH173P) exhibits a moderate level of hypomorphic activity,
and group 3 (Six3bGGins and Six3bR257P) shows only a residual
activity, because they rescue the hdl phenotype at higher doses
but fail to suppress the six3b;six7-deficient phenotype or
dorsalize wild-type embryos. Hence, although at different
degrees, all five HPE-associated Six3 mutant proteins behave
as hypomorphs in vivo.
Haploinsufficiency of Six3 Causes HPE
We previously reported that Six3-heterozygous mice lack any
obvious HPE-like phenotype in the used outbred background
(Lagutin et al., 2003). However, recent results from other mouse
models of HPE have shown strain-specific severity and that pro-
nounced HPE phenotypes are observed in the inbred C57BL/6
mouse strain (Petryk et al., 2004; Zhang et al., 2006). Hence, to
determine whether some of the Six3 mutant proteins also func-
tion as hypomorphs in mammals, we generated two strains of
mutant mice. In one strain, we replaced the endogenous wild-
type Six3 with the HPE-associated Six3V250A mutation that
exhibited moderate hypomorphic activity in the zebrafish as-
says. Because our previously reported Six3+/ strain is main-
tained in an outbred background, we decided to generate an
additional Six3 mutant strain by replacing Six3 with CreERT2 to
overcome the time-consuming backcrossing process; this strain
could eventually be used for lineage tracing and conditional de-
letion. Both strains are now maintained in the C57BL/6 inbred
background. We reasoned that if, as suggested by the zebrafish
experiments described above, the Six3V250A functions as a
hypomorph, then Six3V250A heterozygous and Six3-CreERT2
heterozygous mice (Six3+/) should exhibit some features of
the HPE-like phenotype. However, if Six3V250A functions as
a Six3 antagonist, then only mice carrying this mutation should
exhibit HPE.
To generate theSix3V250A conditional knockinSix3+/cki strain,
we introduced the single base pair substitution T749C into the
first exon of Six3. In addition, we inserted a floxed cassette con-
taining a transcription termination sequence (STOP) (Lakso et al.,
1992) and a neomycin-resistance gene upstream of the first exon
(Figures S2A–S2D). To remove the STOP and activate transcrip-
tion of Six3V250A, we crossed Six3V250A (Six3+/cki) heterozy-
gous mice (in a 129/Sv and C57BL/6 mixed background) with238 Developmental Cell 15, 236–247, August 12, 2008 ª2008 Elsevan available Bf1-Cre strain, which in the 129/SvJ background
exhibits Cre recombinase activity in the telencephalon from
embryonic day (E) 8.5 onward (Hebert and McConnell, 2000).
No obvious phenotypic abnormalities were observed in the gen-
erated Six3+/cki;Bf1-Cre double-heterozygous embryos.
In a mixed background, Bf1-Cre mice reportedly exhibit vari-
able levels of Cre activity outside the regions of endogenous
Bf1 expression (Hebert and McConnell, 2000). Furthermore,
we identified variable levels of Cre activity also in the germline
(unpublished data). Therefore, we took advantage of this variable
activity of Bf1-Cre in the mixed background to permanently de-
lete the STOP and neomycin-resistance cassettes in the germ-
line and generate the Six3V250A knockin mouse line Six3+/ki.
Six3+/cki;Bf1-Cre double-heterozygous mice maintained in the
mixed background were crossed with the Six3+/cki mice, and
pups were genotyped by PCR (Figures S2A–S2D). Approxi-
mately 10% of the Six3+/ki embryos and pups generated with
this strategy exhibited HPE-like phenotypes in the 129/Sv and
C57BL/6 mixed background (Figures S3G and S3I). However,
no phenotypic alterations were observed in an outbred back-
ground (data not shown). Furthermore, the anterior diencephalon
(prethalamus and thalamus) that was absent in Six3–/– embryos
(Lagutin et al., 2003; Lavado et al., 2008) was present in Six3ki/ki
embryos (Figures S4A–S4L). This result supports the proposal
that in mammals Six3V250A functions as a hypomorph.
The Six3-CreERT2 strain (Six3+/) was generated by in-frame
replacement of the 22-nucleotide-long NcoI-BglII restriction
fragment of Six3 exon 1 with CreERT2 cDNA (Figures S2E and
S2F). Upon backcrossing of this mouse strain into the C57BL/6
background, 16% of the F1 Six3+/ embryos exhibited HPE-
like phenotypes (Figures S3J–S3L). When backcrossed further
into the C57BL/6 background, more than 85% of the F3
Six3+/ embryos exhibited HPE-like phenotypes that were in-
distinguishable from those of Six3+/ki embryos in the 129/Sv
and C57BL/6 mixed background. These results suggest that
haploinsufficiency of Six3 causes HPE in a background-depen-
dent manner.
Next, to further investigate Six3 dosage effects on the patho-
genesis of HPE, we determined the amount of Six3 transcripts
present in 8–10 somite stage wild-type, Six3+/, and Six3+/ki
embryos using real-time PCR. The primers and probes used
for this analysis were specific for either the Six3V250A transcript
or for both the wild-type and Six3V250A transcripts. As shown in
Figure S4M, Six3+/ embryos contained approximately half of
the amount of Six3 transcripts present in wild-type littermates;
Six3+/ki and Six3+/ embryos contained similar amounts of
wild-type Six3 transcripts, and Six3+/ki embryos contained simi-
lar amounts of wild-type and Six3V250A transcripts. Therefore,
because Six3V250A exhibits hypomorphic activity, the combined
Six3 activity provided by wild-type and hypomorphic (Six3V250A)
Six3 should be higher inSix3+/ki embryos than inSix3+/ embryos.
This may explain why in comparison to Six3+/ embryos, fewer
Six+/ki embryos exhibited the HPE-like phenotype.
To determine whether the hypomorphic activity of the Six3
mutant proteins was caused by reduced stability, we transfected
NIH 3T3 cells with plasmids expressing various mutant forms of
Six3 and analyzed the protein lysates 48 hr later by western blot.
As shown in Figure S4N and with the exception of Six3GGins
(premature termination of translation), the rest of the analyzedier Inc.
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Six3-Promoted HoloprosencephalyFigure 2. Six3+/ki;Shh+/– Embryos Exhibit a Semilobar HPE-like Phenotype
(A) Electron micrograph of an E11.5 wild-type embryo shows the separation of the medial nasal prominences (MNPs, arrows).
(G) The MNP is not separated in the Six3+/ki;Shh+/– embryo (arrow). The Six3+/ki;Shh+/– embryo also has microcephaly and ocular hypotelorism, as indicated by the
shorter distance between the eyes (bars).
(B and H) Frontal view of E17.5 embryos shows the agenesis of the philtrum in the Six3+/ki;Shh+/– embryo (arrows).
(C–E and I–K) Coronal sections of E17.5 wild-type (C–E) and Six3+/ki;Shh+/– (I–K) embryos stained with hematoxylin and eosin (HE). The cartilage nasal septum
(arrows in the insets in [C] and [I]), the septum (black arrows in [E] and [K]), and the corpus callosum (red arrows in [E] and [K]) are absent in the Six3+/ki;Shh+/–
embryo, and the secondary palate did not fuse properly (arrows in [D] and [J]).
(F and L) Sagittal sections of wild-type and Six3+/ki;Shh+/– embryos with HE staining shows the hypoplasia of the olfactory bulbs in the Six3+/ki;Shh+/– embryo
(arrows).Six3 mutant proteins were expressed at comparable levels, a
result indicating that their stability is not affected.
In conclusion, the five tested mutations affect Six3 function
without affecting the stability of its mRNA or its protein. The
amount of functional Six3 is crucial for patterning the telenceph-
alon; consequently, Six3 haploinsufficiency results in HPE. For
the generation of a mouse model that closely resembles human
HPE and unless otherwise stated, all subsequent experiments
were performed using the Six3+/ki strain.
Six3 Cooperates with Shh in the Genesis of HPE
The low percentage of Six3+/ki embryos exhibiting HPE-like phe-
notypes and strict background dependence are consistent with
the general low penetrance of familial HPE, suggesting that other
genetic or environmental modifiers are involved in the pathogen-
esis of HPE. All HPE-associated genes but Six3 have been
shown to directly or indirectly affect Shh signaling, and Shh mu-
tant embryos exhibit cyclopia. Therefore, we hypothesized that
this pathway could function synergistically with SIX3 mutations
in the pathogenesis of HPE. To test this possibility, we crossed
Six3+/ki mice with phenotypically normal Shh-heterozygous
mice (Shh+/–). From these crosses, approximately 75% of the iso-
lated Six3+/ki;Shh+/– embryos exhibited obvious HPE-like pheno-
types in the 129/Sv and C57BL/6 mixed background (Figure 2).
This frequency increased to 100% when we used a C57BL/6
background (backcrossed for five generations). The HPE-like
phenotype was observed in 100% of the Six3+/;Shh+/– embryos
when the 129/Sv and C57BL/6 mixed background was used. The
phenotype observed in these HPE-like mutant embryos was
similar to that of Six3+/ki or Six3+/- embryos described above
(compare Figures 2I and 2K with Figures S3G–S3L and Figures
S3M–S3O). These results demonstrated thatSix3 andShh syner-
gistically contribute to the pathogenesis of HPE.
Next, we performed a detailed morphological characterization
of the HPE-like phenotype in Six3+/ki;Shh+/– embryos at various
developmental stages. As shown in Figures 2A and 2G, defectsDeveloin the separation of the medial nasal prominence (MNP), ocular
hypotelorism (i.e., shorter distance between the eyes), and mi-
crocephaly (small brain) were obvious in E11.5 Six3+/ki;Shh+/–
embryos assessed via scanning electron microscopy. At
E17.5, the most obvious craniofacial phenotype was the ab-
sence of the philtrum (Figures 2B and 2H) caused by the lack
of separation of the MNP. Coronal sections revealed that the mu-
tant head also lacked the cartilage nasal septum (Figures 2C and
2I), the septum (Figures 2E and 2K), and the corpus callosum
(Figures 2E and 2K). In addition, the mutant head had fusion
defects of the secondary palates (Figures 2D and 2J) and hypo-
plasia of the olfactory bulbs (Figures 2F and 2L). No obvious
defects were identified in the posterior separation of the two
hemispheres by the thalamus (data not shown). No phenotypic
abnormalities were observed in Shh+/– embryos maintained in
a C57BL/6 background (Figures S3D–S3F). The phenotypes
observed in Six3+/ki;Shh+/– embryos were similar to those
described in individuals with semilobar HPE (DeMyer, 1977).
HPE is thought to be associated with dorsoventral patterning
defects of the telencephalon (Muenke and Beachy, 2000; Mon-
uki, 2007). Accordingly, detailed molecular analysis of the telen-
cephalon of E12.5 Six3+/ki;Shh+/– embryos identified putative
dorsoventral patterning defects. As shown in Figure 3, the major
dorsoventral patterning defects decreased in severity from
rostral to caudal. At the most rostral level (Figures 3A–3H), the
cerebral hemispheres of Six3+/ki;Shh+/– embryos were fused
together, and the expression of the dorsal telencephalic markers
Ngn2 and Pax6 (Schuurmans and Guillemot, 2002) was ex-
panded ventrally such that it entirely surrounded the ventricle
(Figures 3A–3D). The expression of the ventral telencephalic
markers Mash1 and Dlx2 (Schuurmans and Guillemot, 2002)
was not detected in the E12.5 mutant telencephalon (Figures
3E–3H). Toward the midcaudal region, similar to what was
seen in the wild-type embryos, a distinct interhemispheric fissure
was present in the mutant brain because of the invagination of
the telencephalic dorsal midline (Figures 3I and 3J). Ngn2pmental Cell 15, 236–247, August 12, 2008 ª2008 Elsevier Inc. 239
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Six3-Promoted HoloprosencephalyFigure 3. Dorsoventral Patterning Defects Are Observed in the
Six3+/ki;Shh+/– Telencephalon
(A–P) Coronal sections of the telencephalon of E12.5 wild-type and Six3+/ki;
Shh+/– embryos.
(A and C) At the most anterior level, two well-separated cerebral hemispheres
are present in the wild-type telencephalon (arrows).Ngn2 andPax6 expression
is restricted to the dorsal telencephalon (arrowheads).
(E and G)Mash1 andDlx2 are expressed in the wild-type ventral telencephalon.
(B and D) In theSix3+/ki;Shh+/– telencephalon, the two cerebral hemispheres are
fused together, and Ngn2 and Pax6 expression has expanded ventrally to en-
circle the single ventricle (arrowhead). The white dotted lines mark the ventricle.240 Developmental Cell 15, 236–247, August 12, 2008 ª2008 Elsevexpression was properly restricted to the dorsal telencephalon
of the mutant embryos; however, its ectopic expression in the
rostral dorsal midline (Figures 3I and 3J) indicated that this struc-
ture failed to properly develop. As indicated by Dlx2 expression,
a single ganglionic eminence (GE) was present in the ventral
telencephalon of the mutant embryos (Figure 3L). This GE
expressed the lateral GE marker Ebf1 (Fuccillo et al., 2006;
Figure 3N) but not the medial GE marker Nkx2.1 (Fuccillo et al.,
2006; Figure 3P). Posteriorly, the cerebral hemispheres of
Six3+/ki;Shh+/– embryos were normally separated by the dien-
cephalon, and the dorsal midline structures (cortical hem, hippo-
campus, and choroid plexus) were normally located (Kimura
et al., 2005; Figures S5A–S5H). Unlike the E12.5 Six3+/ki;Shh+/–
telencephalon, that of Shh/ embryos is composed of a very
small single vesicle with very reduced levels of Dlx2 along the
ventral midline, ventral expansion of Ngn2 throughout, and
a lack of Nkx2.1 or Ebf1 expression (data not shown; Rallu
et al., 2002).
The finding that Six3 becomes haploinsufficient upon addi-
tional inactivation of one allele of Shh suggested that Six3 and
Shh function synergistically in the pathogenesis of HPE. Unlike
the alobar HPE features present inShh/ embryos or in embryos
with defective expression of Shh in the PrCP (Chiang et al., 1996;
Anderson et al., 2002; Lowe et al., 2001), the phenotype of
the Six3+/ki;Shh+/– double-heterozygous telencephalon closely
resembles the clinical features of semilobar HPE (DeMyer, 1977).
Haploinsufficiency of Six3 Fails to Activate Shh
Expression in the Ventral Forebrain
Having established a reproducible mouse model of HPE, we
began investigating the molecular mechanisms of this patho-
genesis. Given the cooperative effect of Six3 and Shh, we first
compared the expression profiles of the two genes’ products
during early development.
Normally, starting at around E7.5 to E8.0 (0–4 somite stage),
Shh expression is detected throughout the axial mesoderm
(Figure 4A; Shimamura et al., 1995), including the PrCP anteriorly
(Figure 4A, inset) and the notochord posteriorly. At this stage,
Six3 expression is high in the ANE, which is located right above
the Shh-expressing PrCP (Figure 4B). Weaker Six3 expression
was detected in the PrCP (Figure 4B, inset). At the 5 somite stage
(E8.0), Six3 expression was maintained in the ANE, whereas Shh
was detected in the ventral midline of the midbrain beside the
(F and H) Mash1 and Dlx2 expression is lost in the Six3+/ki;Shh+/– ventral telen-
cephalon.
(I) At the middle level, the two cerebral hemispheres are separated by the
invagination of the dorsal midline (arrow). Ngn2 expression is restricted to
the wild-type dorsal telencephalon, whereas it is excluded from the dorsal mid-
line (arrowhead).
(K, M, and O) The lateral and medial ganglionic eminences (LGE and MGE,
respectively) are formed ventrally in the wild-type telencephalon, and Dlx2 is
expressed in both the MGE and LGE (K). Ebf1 is expressed in the LGE (M),
and Nkx2.1 expression labels the MGE (O).
(J) In theSix3+/ki;Shh+/– telencephalon,Ngn2 is restricted to the dorsal side, and
the dorsal midline is invaginated (arrow). However, the dorsal midline is Ngn2
positive (arrowhead).
(L and N) Only one ganglionic eminence (GE) is present ventrally in the
Six3+/ki;Shh+/– telencephalon, and it is positive for Dlx2 and Ebf1.
(P) No Nkx2.1 expression was detected in the Six3+/ki;Shh+/– telencephalon.ier Inc.
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Six3-Promoted HoloprosencephalyFigure 4. Shh and Six3 Are Coexpressed in
the RDVM of 12 Somite Stage Embryos
(A) Ventral view of a 1 somite stage embryo with
the anterior side at the top. Shh is expressed in
the axial mesoderm (arrowheads). The transverse
section shows the expression of Shh in the pre-
chordal plate (PrCP) and the rostral axial meso-
endoderm (black arrow in the inset). The level
of the section is indicated by the black dotted
line.
(B) Dorsal view of a 1 somite stage embryo with
the anterior side to the left. Six3 is expressed
strongly in the anterior neuroectoderm (blue
arrow in the inset). Trace levels of Six3 are also
detected in the PrCP (black arrow in the inset).
The level of the section is indicated by the white
dotted line.
(C–H) Lateral views with the anterior side to the
left.
(C) At the 8 somite stage,Shh expression in the neu-
roectoderm starts to extend from the ventral midline
of the midbrain anteriorly into the forebrain (arrow)
and posteriorly into the hindbrain (arrowhead).
(D) Six3 expression is restricted to the ventral fore-
brain (arrow in inset) and the eye field (arrowheads
in inset) at this stage.
(E) At the 12 somite stage, Shh is strongly
expressed in the RDVM (arrow).
(F) Six3 expression remains in the ventral forebrain
and the eye field.
(G) At the 24 somite stage, Shh expression is
downregulated in the RDVM (red arrow), except
in the preoptic area (black arrow). Instead, Shh is expressed in the lateral tuberal hypothalamus (arrowhead). The level of the coronal section shown in the inset
is indicated by the red dotted line.
(H) At this stage, Six3 remains in the ventral forebrain and the eye field.
(I–P) Double immunostaining reveals the colocalization of Six3 (green) and Shh (red) in the RDVM at the 12 somite stage (I–L) and in the preoptic area at the
24 somite stage (M–P). The levels of the sections are indicated by the black dotted lines in (E) and (G), respectively. The images in (K) and (O) and those in (L)
and (P) are merged pictures at lower and higher magnification, respectively.PrCP (data not shown; Shimamura et al., 1995). Around the 8
somite stage (E8.0), Shh expression in the neuroectoderm ex-
tended anteriorly into the RDVM and posteriorly into the hind-
brain (Figure 4C; Shimamura et al., 1995). At this stage, Six3
expression was already restricted to the ventral forebrain and
eye field (Figure 4D). At the 12 somite stage (E8.5), Shh expres-
sion was strong in the RDVM (Figure 4E; Shimamura et al.,
1995), and Six3 was maintained in the ventral forebrain
(Figure 4F). Shh and Six3 expression in the RDVM overlapped
at this stage (Figures 4I–4L) and continued at least until the 18
somite stage (E9.0, data not shown). Later, Shh expression
was excluded from the RDVM, except in the preoptic area
(Figure 4G; Shimamura et al., 1995); its expression also ap-
peared in the lateral tuberal hypothalamus (Figure 4G; Shima-
mura et al., 1995). In the preoptic area, Six3 and Shh expression
continued to colocalize at least until E10.5 (Figures 4M–4P and
data not shown). Around E10.0, Shh expression was detected
in the ventral midline of the telencephalon, whereas Six3 was
broadly expressed in the ventral telencephalon (data not shown;
Shimamura et al., 1995).
On the basis of these expression profiles, we envisaged
two explanations for the HPE-like phenotypes identified in
Six3+/ki;Shh+/ embryos: First, Shh signaling activity in the
PrCP is required for proper patterning of the forebrain (Muenke
and Cohen, 2000), and although Six3 is only weakly expressedDeveloin the PrCP during a very brief period (data not shown), it may
regulate Shh expression in this region. Alternatively, previous
studies have demonstrated that Shh signaling from the PrCP ac-
tivates its own expression and that of other downstream target
genes, such as the homeobox gene Nkx2.1 in the RDVM (Shima-
mura and Rubenstein, 1997). Because Six3 is also expressed in
the RDVM, it might regulate Shh expression in this territory or
provide competence to the ANE to respond to Shh signaling
from the PrCP. To distinguish between these explanations, we
compared the patterns of Shh expression in wild-type and
Six3+/ki;Shh+/– littermates. Shh expression was detected in the
PrCP and RDVM of 10–11 somite stage (E8.5) wild-type
(Figure 5A), Six3+/ki (Figure 5B), and Shh+/– embryos (data not
shown). Although Shh expression was normal in the PrCP of
Six3+/ki;Shh+/– littermates, it was absent from the RDVM
(Figure 5C). Interestingly, Nkx2.1 expression was comparable
between control and Six3+/ki;Shh+/– littermates in this same fore-
brain region (Figures 5D–5F). Nkx2.1 is a target of PrCP-derived
Shh signaling (Shimamura and Rubenstein, 1997); thus, the com-
petence of the Six3+/ki;Shh+/– ANE to respond to Shh signaling
was unaffected.
These results demonstrate that Six3 dosage is crucial for the
activation of Shh expression in the ventral forebrain and that
Six3 in the RDVM and Shh signaling from the PrCP synergistically
regulate Shh expression in the RDVM.pmental Cell 15, 236–247, August 12, 2008 ª2008 Elsevier Inc. 241
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Six3-Promoted HoloprosencephalyLoss of Shh Expression in the RDVM of Six3+/ki;Shh+/–
Embryos Affects the Formation and Function
of Key Telencephalic Signaling Centers
As originally described by Ohkubo et al. (2002), at least three sig-
naling centers that regulate each other work synergistically to
control regional specification and morphogenesis of the telen-
cephalon (Crossley et al., 2001; Monuki, 2007; Monuki and
Walsh, 2001; Ohkubo et al., 2002; Sur and Rubenstein, 2005).
Malfunctions of these patterning centers have been linked to
HPE. The rostral-patterning center (commissural plate) ex-
presses Fgf genes and controls the size and ventral patterning
of the telencephalon (Crossley et al., 2001; Storm et al., 2003,
Figure 5. Shh Expression Is Lost in the
RDVM of Six3+/ki;Shh+/– Embryos
(A–I) In 10–11 somite stage wild-type or Six3+/ki;
Shh+/+ embryos, Shh is expressed in the PrCP
(arrowhead) and the RDVM (arrow) (A and B).
Nkx2.1 colocalizes with Shh in the RDVM (D and
E). Fgf8 demarcates the commissural plate (arrow)
(G and H). In Six3+/ki;Shh+/– embryos, Shh (C) is
expressed normally in the PrCP (arrowhead);
however, it fails to be activated in the RDVM
(arrow). Nkx2.1 (F) and Fgf8 (I) expression in the
mutant embryos is comparable to that of control
embryos.
(J–S) In 15 somite stage wild-type or Six3+/ki;Shh+/+
embryos (J and K),Shh is strongly expressed in the
RDVM (arrow). Gli1 is expressed in the ventral
neural tube, and its expression extends to the com-
missural plate at the rostral end of the neural tube
(arrow) (M and N). Fgf8 continues to be expressed
in the commissural plate (arrow) (P and Q). In
Six3+/ki;Shh+/– embryos (L), Shh expression is
absent from the RDVM (arrow); Gli1 expression
ends posteriorly to the optic vesicles (arrow) (O),
and Fgf8 is dramatically downregulated in the
commissural plate (arrow) (S).
2006). HPE-like phenotype was observed
in Fgf8 hypomorphic and conditional
knockout embryos (Storm et al., 2006).
The dorsal-patterning center expresses
different Bmp and Wnt genes and con-
trols the development of dorsocaudal
structures (cortical hem, hippocampus,
and choroid plexus) (Monuki, 2007; Sur
and Rubenstein, 2005). An excessive
amount of Bmp causes HPE via downre-
gulation of Fgf8 and Shh (Ohkubo et al.,
2002), and in Shh null embryos, Fgf8
expression is lost, and Bmp signaling-
responsive genes are upregulated (Oh-
kubo et al., 2002). Finally, the ventral-
patterning center (ventral midline of the
telencephalon) expresses Shh, whose
function in that region has not yet been
directly established (Monuki, 2007).
Therefore, we next investigated whether
the observed absence of Shh expression
in the RDVM of early-somite stage
Six3+/ki;Shh+/– embryos affected the formation and function of
any of these signaling centers.
Consistent with previous studies showing that the initiation of
Fgf8 expression is independent of Shh signaling (Ohkubo et al.,
2002), Fgf8 expression was normal in the commisural plate of
10–11 somite stage Six3+/ki;Shh+/– embryos (Figure 5I). Later
(15 somite stage, E9.0), and similar to what was observed at ear-
lier stages (Figure 5C), we detected no Shh expression in the
RDVM of those embryos (Figure 5L). A small number of Six3+/ki
embryos also failed to express Shh in the RDVM (data not
shown). As described before, 10% of Six3+/ki embryos exhibit
HPE-like phenotype. Therefore, we hypothesized that the
242 Developmental Cell 15, 236–247, August 12, 2008 ª2008 Elsevier Inc.
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Six3-Promoted HoloprosencephalyFigure 6. Dorsal-Ventral Patterning Centers
and Cell Death Are Affected in the E9.5
Six3+/ki;Shh+/– Telencephalon
(A–H) In E9.5 wild-type embryos, Fgf8 (A) is ex-
pressed in the commissural plate (arrow), Bmp4
(C) covers the dorsal midline of the telencephalon
(arrows) and the anterior diencephalon (arrow-
head), Nkx2.1 (E) demarcates both the hypothala-
mus (arrowhead) and the ventral telencephalon
(arrow), and Shh (G) expression in the RDVM is
downregulated, except in the preoptic area
(arrow), and it is expressed in the lateral tuberal
hypothalamus (arrowhead). In E9.5 Six3+/ki;Shh+/–
embryos, Fgf8 (B) remains absent from the
commissural plate (arrow), Bmp4 (D) fails to be ex-
pressed in the dorsal midline of the telencephalon
(arrows), whereas it is expressed normally in
the diencephalon (arrowhead), and Nkx2.1 (F) is
expressed normally in the hypothalamus (arrow-
head); however, it fails to be activated in the
ventral telencephalon (arrow), and Shh (H) expres-
sion in the preoptic area is lost (arrow), and that in
the lateral tuberal hypothalamus is dramatically
downregulated (arrowhead).
(I–P) Coronal sections of E9.5 embryos processed
for TUNEL (I–L) or anti-PH3 antibody (M–P). The
levels of the sections are labeled by dotted lines in (A) and (B). TUNEL-positive cells are predominantly located in the dorsal and the ventral midline of
the wild-type telencephalon (white arrowheads) and in the optic stalks (yellow arrowheads) (I and K). Comparable amounts of TUNEL-positive cells are detected
in the dorsal midline of the Six3+/ki;Shh+/ telencephalon (white arrowheads) (J and L). However, the ventral midline (white arrowhead) and optic stalk cells
(yellow arrowheads) are TUNEL-negative. Instead, large numbers of TUNEL-positive cells are seen in the lateral dorsal telencephalon (arrows). PH3-
positive cells are detected in the ventricular zone of the wild-type telencephalon (M and O). At the anterior level, fewer PH3-positive cells are detected in the
Six3+/ki;Shh+/– telencephalon (M and N). More posteriorly, the number of PH3-positive cells in the Six3+/ki;Shh+/– telencephalon is comparable to that in the
wild-type (O and P).Six3+/ki embryos that do not express Shh in the RDVM will
subsequently exhibit the HPE-like phenotype.
In control embryos, Gli1, a downstream target and a compo-
nent of the Shh signaling pathway, was normally expressed in
the ventral neural tube, along the entire anteroposterior axis
(Hui et al., 1994; Lee et al., 1997; Figure 5M). However, consis-
tent with the lack of Shh signaling anteriorly (Figure 5L), the
most anterior domain of Gli1 expression in the ventral neural
tube was missing in Six3+/ki;Shh+/– embryos (Figure 5O). At this
later somite stage, Fgf8 expression was also dramatically down-
regulated in the commissural plate of Six3+/ki;Shh+/– embryos
(Figure 4S), suggesting that maintenance of Fgf8 expression in
the commissural plate requires RDVM-derived Shh activity. Ex-
pression analysis performed at E9.5 revealed that Fgf8 remained
absent from the commissural plate of Six3+/ki;Shh+/– embryos
(Figures 6A and 6B).
At E9.5, Bmp4 is expressed in the dorsal midline of the telen-
cephalon and the anterior diencephalon of wild-type embryos
(Figure 6C). In Six3+/ki;Shh+/– littermates, Bmp4 expression was
absent from the dorsal midline of the mutant telencephalon but
remained in the dorsal midline of the anterior diencephalon
(Figure 6D). By contrast, no alterations were detected in the ex-
pression of Wnt8b (Storm et al., 2006) in the dorsocaudal midline
of the mutant telencephalon (data not shown). Previous studies
have shown that Nkx2.1 expression in the ventral telencephalon
is necessary for the subsequent activation of Shh in this region
at around E10.0 (Jeong et al., 2006; Sussel et al., 1999). We
found that Nkx2.1 expression was not activated in the ventral
telencephalon of Six3+/ki;Shh+/– embryos at this later stageDevelo(Figure 6F), although it was normal in the hypothalamus, which
is derived from the RDVM (Figure 6F). Finally, Shh expression
remained absent from the preoptic area (anterior hypothalamus)
of Six3+/ki;Shh+/– embryos at E9.5, and it was dramatically
downregulated in the lateral tuberal hypothalamus (Figures 6G
and 6H).
The E10.5 Six3+/ki;Shh+/– telencephalon was smaller than that of
control littermates (Figures S5I and S5J). In E10.5 Six3+/ki;Shh+/–
embryos, Shh expression remained absent in the preoptic area,
and, most likely because of the lack of Nkx2.1 expression, it
was also not activated in the ventral telencephalon (Figure S5J).
However, Shh expression in the lateral tuberal hypothalamus
was similar to that of control littermates at this stage (Figure S5J),
indicating that in the mutant embryos, Shh expression in this
region was delayed but not lost. Fgf8 and Bmp4 expression
remained missing from the midline of the mutant telencephalon
(Figures S5K–S5N), whereas the pattern of Wnt8b expression
was similar to that of wild-type littermates (Figures S5O and S5P).
In conclusion, the loss of Shh expression in the RDVM of
Six3+/ki;Shh+/– embryos was correlated with and likely affected
the expression of Fgf8, Bmp4, and Shh along the midline of
the telencephalon. The absence of these signaling molecules
promoted the dorsoventral and midline patterning defects
identified in the Six3+/ki;Shh+/– telencephalon.
Abnormal Apoptosis and Cell Proliferation
in Six3+/ki;Shh+/– Embryos
Proper cell proliferation and apoptosis shape the developing tel-
encephalon (Monuki and Walsh, 2001). Because changes in thepmental Cell 15, 236–247, August 12, 2008 ª2008 Elsevier Inc. 243
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Six3-Promoted HoloprosencephalyFigure 7. Six3 and ShhRegulate Each Other
in the RDVM
(A–F) 10–11 somite stage embryos. Shh is
expressed in the wild-type RDVM (arrow) and
prechordal plate (PrCP) (arrowhead) (A). In the
Six3-null embryo, Shh is expressed in the PrCP
(arrowhead) but not in the RDVM (arrow) (B).
Nkx2.1 expression covers the RDVM in the wild-
type embryo (C). In the Six3 null embryo, a group
of cells in the ventral midline are Nkx2 positive
(D). Lhx5 is expressed in the entire wild-type ante-
rior diencephalon (E). Lhx5-positive cells are also
present in Six3 null embryos (F).
(G) 15 somite Six3+/+;Shh-LacZ embryo showing
X-gal staining in the RDVM (arrow).
(H) X-gal staining in the RDVM is lost in the
Six3+/;Shh LacZ littermate.
(I) ChIP and real-time PCR analysis. Fold enrich-
ment is the quantitative ratio between the samples
precipitated with or without anti-Six3 antibody.
For SBE2, the fold enrichment of the head (Six3
positive) samples is around two-fold higher than
that of the posterior trunk (Six3 negative).
However, for a control DNA sequence (6.5 kb
downstream to SBE2), no difference in the fold
enrichment was detected.
(J–Q) Six3 expression is gradually lost in the ven-
tral forebrain of Six3+/ki;Shh+/– embryos; (J)–(M)
show frontal views, and (N)–(Q) show lateral views
(anterior is to the left). At the 8 somite stage,
Six3 expression in the ventral forebrain of the
Six3+/ki;Shh+/– embryo is comparable to that in
the wild-type embryo (arrow) (J and K). At the
12 somite stage, Six3 expression in the ventral
forebrain of the mutant embryo is slightly less that in the wild-type embryo (arrow) (L and M). At the 15-somite stage, Six3 expression in the ventral forebrain
of the mutant embryo is severely downregulated (arrow); however,Six3 expression in the eye field appears normal (arrowhead) (N and O). By the 24-somite stage,
Six3 expression remains dramatically downregulated in the ventral forebrain of the mutant embryo (arrow), whereas that in the optic vesicles and optic stalks is
normal (arrowhead) (P and Q). Insets in (P) and (Q) are frontal views of the wild-type and mutant embryos, respectively.
(R) Proposed model of Six3 action during telencephalon development.activity of Fgf8 or Bmp4 in the telencephalon affect cell prolifer-
ation and apoptosis (Crossley et al., 2001; Ohkubo et al., 2002;
Storm et al., 2003, 2006), we investigated these cellular
responses in the E9.5 Six3+/ki;Shh+/– telencephalon. TUNEL (ter-
minal deoxyribonucleotidyl transferase [TDT]-mediated dUTP-
digoxigenin nick end labeling) positive cells are normally abun-
dant in the dorsal and ventral midlines of the telencephalon
and in the optic stalks at this stage (Figures 6I and 6K). We
detected similar amounts of TUNEL-positive cells in the dorsal
midline of Six3+/ki;Shh+/– embryos; however, none or very few
apoptotic cells were detected in the ventral midline and optic
stalks of the mutant embryos (Figures 6J and 6L). This lack of
cell death in the ventral midline of the Six3+/ki;Shh+/– telenceph-
alon may lead to the fusion of the lateral GE at later stages. Inter-
estingly, a large number of TUNEL-positive cells were present in
the Six3+/ki;Shh+/– lateral dorsal telencephalon (Figures 6J and
6L); this alteration may cause the microcephaly phenotype in
the mutant embryos. We also assayed for the M phase cell-cycle
marker phosphohistone-3 (PH3) to examine changes in cell pro-
liferation. A small reduction in the number of PH3-positive cells
was detected in the Six3+/ki;Shh+/– lateral telencephalon at this
stage (Figures 6M and 6N and Figures S5Q and S5R). In conclu-
sion, local changes in cell proliferation and apoptosis in the244 Developmental Cell 15, 236–247, August 12, 2008 ª2008 ElsevSix3+/ki;Shh+/– telencephalon may contribute to the morphologi-
cal defects observed in the Six3+/ki;Shh+/– brain.
Six3 and Shh Regulate Each Other
in the Ventral Forebrain
We have demonstrated that Six3 in the RDVM and Shh signaling
from the PrCP synergistically regulate Shh expression in the
RDVM. To validate these results and confirm that Six3 is an
upstream regulator of Shh and its activity is required for Shh ex-
pression in the ventral forebrain, we analyzed the expression of
Shh in Six3 null embryos (Lagutin et al., 2003). At the 10 somite
stage, Shh was expressed in the Six3 null PrCP; however, its
expression failed to extend anteriorly into the RDVM
(Figure 7B). Confirmation that at least part of the RDVM remained
in the Six3 null brain was provided by the normal expression of
Nkx2.1 and the anterior diencephalic marker Lhx5 (Sheng
et al., 1997; Figures 7C–7F). These results demonstrate that
Six3 activity is necessary for Shh expression in the RDVM.
Next, we used a Shh-LacZ reporter line that recapitulates the
endogenous pattern of Shh expression in the ventral forebrain
(Jeong et al., 2006) to determine whether lack of Six3 will affect
expression of the reporter gene. F2 Six3+/ mice were crossed
with the Shh-LacZ reporter strain, and, as expected, X-galier Inc.
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somites) Six3+/+;Shh-LacZ embryos (Figure 7G); however, this
staining was absent in Six3+/;Shh-LacZ littermates (Figure 7H).
In a related paper, Jeong et al. (2008) reported that this Shh reg-
ulatory element contains a Six3-binding site (SBE2: Shh Brain
Enhancer-2), and this site was mutated in an individual with
semilobar HPE. Introduction of this mutation into the Shh-LacZ
reporter strain caused severe downregulation of the reporter
gene expression in the RDVM (Jeong et al., 2008). Therefore,
to determine whether Six3 binds directly to this regulatory
element and activates Shh expression in vivo, we performed
chromatin immunoprecipitation (ChIP) using chromatin from
the Six3-expressing head or the Six3-negative posterior trunk
of E9.0 (13–18 somites) mouse embryos. Using Taqman-based
real-time PCR, we detected around 2-fold enrichment of SBE2
in the head chromatin compared to that in the posterior trunk
(Figure 7I). However, equal amounts of a control fragment
located 6.5 kb downstream of SBE2 were detected in the two
samples (Figure 7I). Hence, in the RDVM Six3 acts as a direct
upstream activator of Shh expression.
Finally, we also analyzedSix3 expression inSix3+/ki;Shh+/– em-
bryos at different stages. At the 8 somite stage, Six3 expression
was normal in the ventral forebrain of the mutant embryos (Fig-
ures 7J and 7K). Eight hours later (12 somite stage), and in agree-
ment with the loss of Shh expression in the RDVM, Six3
expression was slightly weaker in the mutant ventral forebrain
(Figures 7L and 7M). Fourteen hours later (15 somite stage),
Six3 expression was severely downregulated in the mutant ven-
tral forebrain; however, its expression around the developing
eyes appeared to be normal (Figures 7N and 7O). By E9.5,
Six3 expression in the mutant ventral forebrain remained dra-
matically downregulated, but it was normal in the optic vesicles
and optic stalks (Figures 7P and 7Q). These results indicate that
a positive regulatory loop between Six3 and Shh operates during
the patterning of the ventral forebrain. Therefore, we concluded
that Six3 and Shh regulate each other in the RDVM.
DISCUSSION
Using zebrafish-based in vivo assays, we determined that al-
though at different degrees, HPE-associated Six3 mutant proteins
function as hypomorphs. Analysis of generated mouse models re-
vealed that haploinsufficiency of Six3 causes HPE and that Six3
and Shh cooperate in the pathogenesis of HPE; i.e., the loss of
one copy of Shh in the presence of one hypomorphic Six3 muta-
tion dramatically increased the percentage of embryos with HPE
features. These findingsprovide experimental evidence insupport
of the multihit hypothesis proposed for the pathogenesis of HPE
(Ming and Muenke, 2002), whereby hypomorphic mutations in
SIX3 become haploinsufficient when combined with mutations
in different genes that impair SHH signaling.
Importantly, we have determined thatSix3 is a direct upstream
activator of Shh and that its activity is necessary for Shh expres-
sion in the ventral forebrain. Shh signaling plays multiple roles
during forebrain development, including the establishment of
the ventral midline, separation of the eye field, and growth and
patterning of the telencephalon (Chiang et al., 1996; Shimamura
and Rubenstein, 1997). Previous studies have suggested that
temporal perturbation in Shh signaling is associated with theDeveloseverity of the resulting HPE phenotype (Cordero et al., 2004).
In Six3+/ki;Shh+/– embryos, early Shh expression in the PrCP
remained unaffected and was sufficient to establish the ventral
midline and to separate the eye fields. However, the lack of
Shh expression in the RDVM at later stages resulted in the semi-
lobar HPE phenotype. This phenotype was similar to that
described for Cdo–/– embryos, in which Shh expression in the
RDVM is lost (Zhang et al., 2006). These results confirm that
the severity of the HPE phenotype is closely related to the stages
at which perturbations in the Shh signaling pathway occur; i.e.,
the earlier the alteration, the more severe the resulting HPE
phenotype.
On the basis of the original model proposed by Ohkubo et al.
(2002), we propose a modified model that incorporates Six3
function in the dorsoventral patterning of the telencephalon
and in promoting HPE when mutated (Figure 7R). At the 8–10
somite stage, Six3 directly activates Shh expression in the
RDVM. Upon activation, Shh activity from the RDVM positively
feeds back to maintain Six3 expression in the ventral forebrain
and promotes Fgf8 expression in the commissural plate via
a yet-unknown mechanism. Fgf8 activity from the commissural
plate positively regulates Six3 expression in the ventral forebrain
and is required for the proper expression of Bmp4 in the dorsal
midline. Fgf8 signaling also activates the expression of Nkx2.1
in the ventral telencephalon. Subsequently, Nkx2.1 activates
Shh expression in the ventral telencephalon. Thus, three signal-
ing centers are established along the midline, and they function
synergistically to ensure the proper dorsoventral patterning and
morphogenesis of the telencephalon.
In Six3 haploinsufficient embryos, the amount of Six3 activity
is not enough to activate Shh expression in the RDVM, and con-
sequently, this leads to the loss of all of the above-mentioned
signaling molecules in the telencephalon. The fact that Nkx2.1
failed to be activated in the Six3 haplosufficient embryos sug-
gests that Six3 is required for induction of telencephalic Nkx2.1
expression, which in turn is required for the induction of Shh ex-
pression. However, this cascade is not essential for preventing
ventral holoprosencephaly, because Nkx2.1 mutant embryos
do not exhibit HPE (Sussel et al., 1999). Rather, the maintenance
of Fgf8 expression by Six3 appears to be more relevant for HPE
pathogenesis because Fgf8 severe hypomorphs exhibit this
phenotype (Storm et al., 2006). Conversely, the fact that Fgf8
promotes Six3 expression (Storm et al., 2006) suggests that re-
duced Six3 expression likely contributes to the HPE phenotype
described in Fgf8 hypomorphs.
Consistent with our model, Marcucio et al. have shown that
blocking Shh signaling specifically from the RDVM in 10 somite
stage chicken embryos causes loss of Shh expression in the
ventral telencephalon, reduction in expression of the ventral
markers Nkx2.1 and Dlx2, and ventral expansion of the dorsal
marker Pax6 (Marcucio et al., 2005). Furthermore, as suggested
by the analysis of six3b/;smo/ mutant zebrafish embryos
(A.I. and L.S.K., unpublished data), the lack of Six3 expression
observed in the ventral forebrain of Six3+/ki;Shh+/ embryos
could also contribute to the dorsal-ventral patterning defects ob-
served in these mutant embryos in a Shh-independent manner.
In summary, we have identified Six3 as a direct upstream reg-
ulator of Shh expression and shown that Six3 and Shh signaling
from the PrCP synergistically activate Shh expression in thepmental Cell 15, 236–247, August 12, 2008 ª2008 Elsevier Inc. 245
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transcriptional activity. SIX3 mutations in human are associated
with HPE phenotypes ranging from mild (microform) to severe
(cyclopia). However, in Six3+/, Six3+/;Shh+/–, Six3+/ki , and
Six3+/ki;Shh+/– embryos, semilobar HPE was the predominant
phenotype observed in the C57BL/6 background; more or less
severe forms of HPE were rarely observed in embryos with mixed
genetic backgrounds (Figure S6). These phenotypic variations
were probably caused by additional genetic modifiers.
EXPERIMENTAL PROCEDURES
Details on the quantitative analysis of Six3 transcripts, plasmids, and western
blot analysis are in the Supplemental Data.
Mice
NMRI and C57BL/6 mice were purchased from the Jackson Laboratory. Shh+/–
mice were provided by Chin Chiang (Vanderbilt University, Nashville, TN), Bf1-
Cre mice were provided by Susan McConnell (Stanford University, Stanford,
CA), and Six3+/– and Shh-LacZ (447L17blacZ) mice have been previously re-
ported (Lagutin et al., 2003; Jeong et al., 2006). Generation of the different
mouse strains is described in the Supplemental Data. All of the mouse exper-
iments were approved by the St. Jude Children’s Research Hospital Animal
Care and Use committee.
Zebrafish
Mutant six3b Synthetic RNA
For the generation of the HPE-related mutant forms, wild-type six3b zebrafish
cDNA (Kobayashi et al., 1998) was used as a template for site-specific muta-
genesis with the QuikChange Site-Directed Mutagenesis Kit (Stratagene, La
Jolla, CA). Mutant DNAs were linearized, and synthetic RNAs were transcribed
with the mMESSAGE mMACHINE High Yield Capped RNA Transcription Kit
(SP6 polymerase) (Ambion, Austin, TX).
RNA Injection
The hdl/tcf3/Mutant Rescue Assay.Homozygous hdlmutant embryos at the
one-cell stage (Kim et al., 2000) were injected with either wild-type six3b or the
mutant RNAs. Embryos were then evaluated at 55 hpf and categorized accord-
ing to the degree of rescue of the eyeless hdl phenotype.
The six3bvu87/vu87 Mutant-six7 Morphant Suppression Assay. An antisense
morpholino oligonucleotide (MO) against the 50 UTR of six7 (2 ng) was injected
into six3bvu87/vu87 mutant embryos (Inbal et al., 2007). The six7 MO was coin-
jected with wild-type or mutant six3b RNA constructs at the one-cell stage.
Embryos were scored at 55 hpf; ten representative embryos were selected
from each injected sample and photographed. The eye size of the embryos
was digitally measured with Adobe Photoshop (Adobe Systems, San Jose,
CA) on a 0 to 6.5 point scale, with 5.0 to 6.5 points being equivalent to full-sized
eyes. Results were then quantified for statistical significance with the t test in
comparison to six3bvu87/vu87-six7 mutant morphants.
Experimental details on the dorsalization assay are described in the Supple-
mental Data.
Chromatin Immunoprecipitation
ChIP was performed as previously described (Cawley et al., 2004), with slight
modifications that are described in the Supplemental Data.
In Situ Hybridization, Immunohistochemistry, and X-Gal Staining
For in situ hybridization, embryos were fixed in 4% paraformaldehyde (PFA) at
4C overnight and processed as described (Lagutin et al., 2003). For immuno-
histochemistry, embryos were fixed in 4% PFA on ice for 30 min and pro-
cessed for cryosection. Immunohistochemistry was performed on frozen sec-
tions (10 mm) as described (Liu et al., 2006). The primary antibodies were rabbit
anti-Six3 and mouse anti-Shh (Hybridoma Bank), and the secondary anti-
bodies were Alexa 488-conjugated donkey anti-rabbit (Molecular Probes)
and Cy3-conjugated goat anti-mouse (Jackson Laboratories). DAB immunos-
taining was performed with rabbit anti-Pax6 (Covance) as the primary anti-
body, donkey anti-rabbit biotin-conjugated secondary antibody (Jackson Lab-246 Developmental Cell 15, 236–247, August 12, 2008 ª2008 Elsevoratories), and diaminobenzidine as substrate (ABC kit, Vector). X-gal staining
was performed as described (Lagutin et al., 2003).
TUNEL and Proliferation Assays
TUNEL was performed on frozen sections (10 mm) with the ApoTag Plus Per-
oxidase Kit (Chemicon) according to the manufacturer’s instructions. PH3 im-
munohistochemistry was performed with mouse anti-PH3 (Upstate), with Cy3-
conjugated goat anti-mouse (Jackson Laboratories) as a secondary antibody.
SUPPLEMENTAL DATA
Supplemental Data include six figures and Supplemental Experimental Proce-
dures and can be found with this article online at http://www.developmentalcell.
com/cgi/content/full/15/2/236/DC1/.
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